Department of Food Engineering, Engineering Faculty, Çukurova University, Adana, Turkey.
Faculty of Education and Arts, Sohar University, Sohar, 311, Sultanate of Oman.
Curr Drug Targets. 2023;24(7):613-625. doi: 10.2174/1389450124666230519121940.
Salmonellosis, which is typically distinguished by an immediate onset of fever, abdominal pain, diarrhea, nausea, and vomiting, is a bacterial infection caused by Salmonella. The rising incidence of antibiotic resistance in Typhimurium is a major worldwide problem, and a better knowledge of the distribution of antibiotic resistance patterns in is critical for selecting the best antibiotic for infection treatment. In this work, the efficiency of bacteriophage therapy of vegetative cells and biofilms of was investigated.
Based on their host ranges, five Bacteriophages were chosen for therapy against 22 Salmonella isolates collected from various sources. PSCs1, PSDs1, PSCs2, PSSr1, and PSMc1 phages were found to exhibit potent anti- properties. In a 96-well microplate, the efficacy of bacteriophage therapy (10-10 PFU/mL) against biofilm formers was first tested. A bacteriophage treatment (10 PFU/mL) was subsequently applied in the laboratory for 24 hours to minimize adhering to the surfaces of gallstones and teeth. In 96-well microplate experiments, bacteriophage treatment inhibited biofilm development and reduced biofilm by up to 63.6% ( ≤ 0.05).
When compared to controls, bacteriophages (PSCs1, PSDs1, PSCs2, PSSr1, PSMc1) demonstrated a rapid drop in the populations of biofilms generated on the surfaces of gallstones and teeth where the structure of the bacteria in the biofilm was broken and holes were created.
Clearly, this study indicated that phages might be employed to eliminate biofilms on gallstone and tooth surfaces.
沙门氏菌病通常以发热、腹痛、腹泻、恶心和呕吐为特征,是由沙门氏菌引起的细菌感染。鼠伤寒沙门氏菌对抗生素耐药性的上升是一个全球性的主要问题,更好地了解鼠伤寒沙门氏菌的抗生素耐药模式分布对于选择治疗感染的最佳抗生素至关重要。在这项工作中,研究了噬菌体治疗鼠伤寒沙门氏菌的营养细胞和生物膜的效率。
根据它们的宿主范围,选择了五种噬菌体来对抗从各种来源收集的 22 株沙门氏菌分离株进行治疗。PSCs1、PSDs1、PSCs2、PSSr1 和 PSMc1 噬菌体被发现具有强大的抗特性。在 96 孔微量滴定板中,首先测试了噬菌体治疗(10-10 PFU/mL)对生物膜形成者的疗效。随后在实验室中应用噬菌体治疗(10 PFU/mL)24 小时,以最大限度地减少结石和牙齿表面的 黏附。在 96 孔微量滴定板实验中,噬菌体治疗抑制生物膜的发展,并将生物膜减少多达 63.6%( ≤ 0.05)。
与对照组相比,噬菌体(PSCs1、PSDs1、PSCs2、PSSr1、PSMc1)在结石和牙齿表面形成的生物膜中 细菌的结构被破坏并产生孔的情况下,生物膜中 细菌的数量迅速下降。
显然,这项研究表明噬菌体可能被用来消除结石和牙齿表面的 生物膜。